-
1
-
-
0024357770
-
Post viral fatigue syndrome: Evidence for underlying organic disturbance in the muscle fiber
-
Jamal GA, Hansen S. Post viral fatigue syndrome: evidence for underlying organic disturbance in the muscle fiber. Eur Neurol 1989;29:273-276.
-
(1989)
Eur Neurol
, vol.29
, pp. 273-276
-
-
Jamal, G.A.1
Hansen, S.2
-
2
-
-
0002137451
-
Serological diagnosis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome
-
Lisak R, ed. New York: Marcel Dekker
-
Lennon VA. Serological diagnosis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome. In: Lisak R, ed. Handbook of myasthenia gravis. New York: Marcel Dekker, 1994:149-164.
-
(1994)
Handbook of Myasthenia Gravis
, pp. 149-164
-
-
Lennon, V.A.1
-
3
-
-
0029030949
-
Calcium-channel antibodies in the Lambert-Eaton Syndrome and other paraneoplastic syndromes
-
Lennon VA, Kryzer TJ, Griesmann MS, et al. Calcium-channel antibodies in the Lambert-Eaton Syndrome and other paraneoplastic syndromes. N Engl J Med 1995;332:1467-1474.
-
(1995)
N Engl J Med
, vol.332
, pp. 1467-1474
-
-
Lennon, V.A.1
Kryzer, T.J.2
Griesmann, M.S.3
-
4
-
-
0028799998
-
Chronic fatigue syndrome (Myalgic Encephalopathy)
-
Plioplys S, Plioplys AV. Chronic fatigue syndrome (Myalgic Encephalopathy). South Med J 1995;88:993-1000.
-
(1995)
South Med J
, vol.88
, pp. 993-1000
-
-
Plioplys, S.1
Plioplys, A.V.2
-
5
-
-
0014330860
-
Limbic encephalitis and its association with carcinoma
-
Corsellis JAN, Goldberg GF, Norton AR. Limbic encephalitis and its association with carcinoma. Brain 1968;91:481-495.
-
(1968)
Brain
, vol.91
, pp. 481-495
-
-
Corsellis, J.A.N.1
Goldberg, G.F.2
Norton, A.R.3
-
6
-
-
0026547716
-
Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy: A clinical study of 71 patients
-
Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy: a clinical study of 71 patients. Medicine 1992;71: 59-72.
-
(1992)
Medicine
, vol.71
, pp. 59-72
-
-
Dalmau, J.1
Graus, F.2
Rosenblum, M.K.3
Posner, J.B.4
-
7
-
-
0024420189
-
The fatigue severity scale: Application to patients with multiple sclerosis and systemic lupus erythematosus
-
Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-1123.
-
(1989)
Arch Neurol
, vol.46
, pp. 1121-1123
-
-
Krupp, L.B.1
Larocca, N.G.2
Muir-Nash, J.3
Steinberg, A.D.4
-
8
-
-
0029080315
-
Serum levels of carnitine in chronic fatigue syndrome: Clinical correlates
-
Plioplys AV, Plioplys S. Serum levels of carnitine in chronic fatigue syndrome: clinical correlates. Neuropsychobiology 1995;32:132-138.
-
(1995)
Neuropsychobiology
, vol.32
, pp. 132-138
-
-
Plioplys, A.V.1
Plioplys, S.2
-
9
-
-
0023874790
-
Chronic fatigue syndrome: A working case definition
-
Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988; 108:387-389.
-
(1988)
Ann Intern Med
, vol.108
, pp. 387-389
-
-
Holmes, G.P.1
Kaplan, J.E.2
Gantz, N.M.3
-
10
-
-
0027973857
-
The chronic fatigue syndrome: A comprehensive approach to its definition and study
-
Fukuda K, Strauss SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994;121:953-959.
-
(1994)
Ann Intern Med
, vol.121
, pp. 953-959
-
-
Fukuda, K.1
Strauss, S.E.2
Hickie, I.3
-
11
-
-
0027997764
-
Paraneoplastic autoantibodies: The case for a descriptive generic nomenclature
-
Lennon VA. Paraneoplastic autoantibodies: the case for a descriptive generic nomenclature. Neurology 1994;44:2236-2240.
-
(1994)
Neurology
, vol.44
, pp. 2236-2240
-
-
Lennon, V.A.1
-
12
-
-
0025827369
-
Chronic fatigue syndrome: Clinical condition associated with immune activation
-
Landay AL, Jessop C, Lennette ET, et al. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet 1991;338:707-712.
-
(1991)
Lancet
, vol.338
, pp. 707-712
-
-
Landay, A.L.1
Jessop, C.2
Lennette, E.T.3
-
13
-
-
0021907540
-
Immune function in chronic active Epstein-Barr virus infection
-
Kibler R, Lucas D, Hicks MJ, et al. Immune function in chronic active Epstein-Barr virus infection. J Clin Immunol 1985;5:46-54.
-
(1985)
J Clin Immunol
, vol.5
, pp. 46-54
-
-
Kibler, R.1
Lucas, D.2
Hicks, M.J.3
-
14
-
-
0022356695
-
Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis)
-
Tosato G, Straus S, Henle W, et al. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). J Immunol 1985; 134:3082-3088.
-
(1985)
J Immunol
, vol.134
, pp. 3082-3088
-
-
Tosato, G.1
Straus, S.2
Henle, W.3
-
15
-
-
0024316713
-
Immunological abnormalities in the chronic fatigue syndrome
-
Lloyd AR, Wakefield D, Boughton CR, et al. Immunological abnormalities in the chronic fatigue syndrome. Med J Aust 1989;151:122.
-
(1989)
Med J Aust
, vol.151
, pp. 122
-
-
Lloyd, A.R.1
Wakefield, D.2
Boughton, C.R.3
-
16
-
-
0025322432
-
Immunologic abnormalities in chronic fatigue syndrome
-
Klimas NG, Salvato FR, Morgan R, et al. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 1990; 28:1403-1410.
-
(1990)
J Clin Microbiol
, vol.28
, pp. 1403-1410
-
-
Klimas, N.G.1
Salvato, F.R.2
Morgan, R.3
-
17
-
-
0023904311
-
IgG subclass deficiencies in chronic fatigue syndrome
-
Komaroff AL, Geiger AM, Wormsley S. IgG subclass deficiencies in chronic fatigue syndrome. Lancet 1988;1:1288.
-
(1988)
Lancet
, vol.1
, pp. 1288
-
-
Komaroff, A.L.1
Geiger, A.M.2
Wormsley, S.3
-
18
-
-
0025770312
-
Defining the chronic fatigue syndrome
-
Holmes GP. Defining the chronic fatigue syndrome. Rev Inf Dis 1991;13(suppl):53-55.
-
(1991)
Rev Inf Dis
, vol.13
, Issue.SUPPL.
, pp. 53-55
-
-
Holmes, G.P.1
|